slotkoers
Shanghai S.E.
00:00:00 25-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
19,87
CNY
|
-0,25%
|
|
-5,56%
|
+6,83%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
13.614
|
12.508
|
13.948
|
18.276
|
18.992
|
20.287
|
-
|
-
|
Bedrijfswaarde
1 |
11.835
|
10.105
|
13.948
|
18.276
|
18.992
|
20.287
|
20.287
|
20.287
|
K/w-verhouding
|
12,9
x
|
12,4
x
|
14,9
x
|
15,9
x
|
14,3
x
|
13,6
x
|
12,1
x
|
11,1
x
|
Dividendrendement
|
2,33%
|
2,42%
|
-
|
-
|
1,38%
|
1,51%
|
1,71%
|
-
|
Marktkapitalisatie/omzet
|
1,45
x
|
1,47
x
|
1,53
x
|
1,93
x
|
1,86
x
|
1,79
x
|
1,6
x
|
1,58
x
|
Bedrijfswaarde/omzet
|
1,45
x
|
1,47
x
|
1,53
x
|
1,93
x
|
1,86
x
|
1,79
x
|
1,6
x
|
1,58
x
|
Bedrijfswaarde/EBITDA
|
8,39
x
|
7,8
x
|
8,8
x
|
9,48
x
|
8,86
x
|
8,75
x
|
7,87
x
|
7,56
x
|
Bedrijfswaarde/FCF
|
11.339.571
x
|
11.859.366
x
|
-
|
-
|
18.451.781
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
0%
|
-
|
-
|
-
|
Price to Book
|
1,58
x
|
1,35
x
|
1,41
x
|
1,86
x
|
1,74
x
|
1,67
x
|
1,5
x
|
1,36
x
|
Aantal aandelen (in duizenden)
|
1.043.238
|
1.043.238
|
1.043.238
|
1.021.567
|
1.021.061
|
1.020.978
|
-
|
-
|
Referentieprijs
2 |
13,05
|
11,99
|
13,37
|
17,89
|
18,60
|
19,87
|
19,87
|
19,87
|
Datum van publicatie
|
20-03-20
|
18-03-21
|
24-03-22
|
27-03-23
|
21-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
9.381
|
8.504
|
9.112
|
9.447
|
10.222
|
11.360
|
12.645
|
12.878
|
EBITDA
1 |
1.623
|
1.605
|
1.585
|
1.928
|
2.142
|
2.320
|
2.579
|
2.684
|
Bedrijfsresultaat (EBIT)
1 |
1.262
|
1.229
|
1.137
|
1.406
|
1.515
|
1.780
|
2.007
|
2.178
|
Operationele Marge
|
13,46%
|
14,46%
|
12,48%
|
14,88%
|
14,82%
|
15,67%
|
15,87%
|
16,92%
|
Resultaat voor belastingen (EBT)
1 |
1.262
|
1.215
|
1.121
|
1.415
|
1.567
|
1.788
|
2.016
|
2.188
|
Nettowinst (verlies)
1 |
1.055
|
1.005
|
935,7
|
1.164
|
1.333
|
1.521
|
1.714
|
1.862
|
Nettomarge
|
11,25%
|
11,82%
|
10,27%
|
12,32%
|
13,04%
|
13,39%
|
13,55%
|
14,45%
|
WPA
2 |
1,011
|
0,9635
|
0,8969
|
1,124
|
1,300
|
1,463
|
1,647
|
1,790
|
Free Cash Flow
|
1.201
|
1.055
|
-
|
-
|
1.029
|
-
|
-
|
-
|
FCF-marge
|
12,8%
|
12,4%
|
-
|
-
|
10,07%
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
73,96%
|
65,73%
|
-
|
-
|
48,04%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
113,79%
|
104,93%
|
-
|
-
|
77,21%
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,3040
|
0,2900
|
-
|
-
|
0,2570
|
0,3000
|
0,3400
|
-
|
Datum van publicatie
|
20-03-20
|
18-03-21
|
24-03-22
|
27-03-23
|
21-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2024 Q1
|
---|
Omzet
1 |
2.835
|
EBITDA
|
-
|
Bedrijfsresultaat (EBIT)
|
-
|
Operationele Marge
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
Nettowinst (verlies)
1 |
416,1
|
Nettomarge
|
14,68%
|
WPA
|
-
|
Dividend per aandeel
|
-
|
Datum van publicatie
|
25-04-24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
1.779
|
2.404
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
1.201
|
1.055
|
-
|
-
|
1.029
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
12,9%
|
11,3%
|
9,78%
|
11,7%
|
12,4%
|
12,3%
|
12,5%
|
11,9%
|
ROA (netto-inkomsten/totale activa)
|
9,78%
|
8,49%
|
-
|
-
|
8,71%
|
9,3%
|
9,55%
|
9,5%
|
Totale activa
1 |
10.792
|
11.846
|
-
|
-
|
15.298
|
16.351
|
17.944
|
19.595
|
Nettoactief per aandeel
2 |
8,250
|
8,910
|
9,490
|
9,610
|
10,70
|
11,90
|
13,30
|
14,70
|
Cashflow per aandeel
2 |
1,380
|
1,300
|
1,290
|
1,290
|
1,570
|
1,870
|
2,140
|
2,340
|
Capex
1 |
239
|
305
|
480
|
522
|
602
|
705
|
797
|
643
|
Capex/omzet
|
2,55%
|
3,59%
|
5,27%
|
5,52%
|
5,88%
|
6,21%
|
6,3%
|
5%
|
Datum van publicatie
|
20-03-20
|
18-03-21
|
24-03-22
|
27-03-23
|
21-03-24
|
-
|
-
|
-
|
Laatste slotkoers
19,87
CNY Gemiddelde koersdoel
25,58
CNY Spread / Gemiddelde doel +28,74% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +6,83% | 2,79 mld. | | +55,19% | 815 mld. | | +47,26% | 654 mld. | | -6,09% | 354 mld. | | +21,92% | 337 mld. | | +18,40% | 247 mld. | | +3,64% | 229 mld. | | +12,98% | 219 mld. | | +10,86% | 171 mld. | | -2,78% | 159 mld. |
Farmaceutische producten - Andere
|